Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats

Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats

ABSTRACT: Background: Although dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia, there is an identified relationship between the utilization of D2-like R agonists and the progress of myocard...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Fouad Shalaby, MD, Hekma A. Abd El Latif, PhD, Mohamed El Yamani, PhD, May Ahmed Galal, PhD, Sherifa Kamal, PhD, Ikhlas Sindi, PhD
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
Cardiovascular
Diabetic nephropathy
Dopamine receptors
Myocardial injury
Sarpogrelate
Therapeutics. Pharmacology
RM1-950
Online Access:https://doaj.org/article/4071e837d64440c69aa406399cbef68a
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/4071e837d64440c69aa406399cbef68a

Similar Items